| Trial ID: | L2988 |
| Source ID: | NCT05482789
|
| Associated Drug: |
Exenatide
|
| Title: |
Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
|
| Acronym: |
|
| Status: |
RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Gestational Diabetes
|
| Interventions: |
DRUG: Exenatide
|
| Outcome Measures: |
Primary: Area Under the Plasma Concentration Versus Time Curve (AUC) of glucose, Glucose concentration over the course of each study visit following mixed tolerance test, Baseline and 1 week later | Secondary: Area Under the Plasma Concentration Versus Time Curve (AUC) of exenatide, Drug concentration over the course of the second study visit, 1 week after study enrollment
|
| Sponsor/Collaborators: |
Sponsor: Maisa N. Feghali, MD
|
| Gender: |
FEMALE
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
13
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2023-04-12
|
| Completion Date: |
2025-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2025-01-10
|
| Locations: |
Magee Womens Hospital of UPMC, Pittsburgh, Pennsylvania, 15213, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT05482789
|
